Adesse D, Iacobas DA, Iacobas S, Garzoni LR, Meirelles Mde N, Tanowitz HB, Spray DC. Transcriptomic signatures of alterations in a myoblast cell line infected with four distinct strains of Trypanosoma cruzi. Am. J. Trop. Med. Hyg.. 2010 May;82(5):846-54.
Adesse D, Lisanti MP, Spray DC, Machado FS, Meirelles MD, Tanowitz HB, Garzoni LR. Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heart. Cell Cycle. 2010 Apr 10;9(8).
Andrade LO, Galvão LM, Meirelles Mde N, Chiari E, Pena SD, Macedo AM. Differential tissue tropism of Trypanosoma cruzi strains: an in vitro study. Memórias do Instituto Oswaldo Cruz. 2010 Sep;105(6):834-7.
Batista Dda G, Batista MM, de Oliveira GM, do Amaral PB, Lannes-Vieira J, Britto CC, Junqueira A, Lima MM, Romanha AJ, Sales Junior PA, Stephens CE, Boykin DW, Soeiro Mde N. Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas disease treatment. Antimicrob Agents Chemother. 2010 Jul; 54(7):2940-52. Epub 2010 May 10.
Batista DG, Pacheco MG, Kumar A, Branowska D, Ismail MA, Hu L, Boykin DW, Soeiro MN. Biological, ultrastructural effect and subcellular localization of aromatic diamidines in Trypanosoma cruzi. Parasitology. Journal Cambridge. 2010 Feb;137(2):251-9. Epub 2009 Sep 21.
doi |
doi |
Campos MC, Salomão K, Castro-Pinto DB, Leon LL, Barbosa HS, Maciel MA, de Castro SL. Croton cajucara crude extract and isolated terpenes: activity on Trypanosoma cruzi. Parasitol Res. 2010 Oct;107(5):1193-204. Epub 2010 Aug 3.
Capriles PV, Guimarães AC, Otto TD, Miranda AB, Dardenne LE, Degrave WM. Structural modelling and comparative analysis of homologous, analogous and specific proteins from Trypanosoma cruzi versus Homo sapiens: putative drug targets for Chagas disease treatment. BMC Genomics. 2010 Oct 29;11:610.
Scielo |
doi |
Scielo |
doi |
doi |
De Melo Medeiros M, Araújo-Jorge TC, Batista WS, da Silva TM, de Souza AP. Trypanosoma cruzi infection: Do distinct populations cause intestinal motility alteration? Parasitol Res. 2010 Jun;107(1):239-42. Epub 2010 May 8.
De Souza AP, Sieberg R, Li H, Cahill HR, Zhao D, Araújo-Jorge TC, Tanowitz HB, Jelicks LA. The role of selenium in intestinal motility and morphology in a murine model of Trypanosoma cruzi infection. Parasitol Res. 2010 May;106(6):1293-8. Epub 2010 Feb 27.
De Souza EM, Nefertiti AS, Bailly C, Lansiaux A, Soeiro MN. Differential apoptosis-like cell death in amastigote and trypomastigote forms from Trypanosoma cruzi-infected heart cells in vitro. Cell Tissue Res. 2010 Jul;341(1):173-80. Epub 2010 May 22.
Ennes-Vidal V, Menna-Barreto RF, Santos AL, Branquinha MH, d'Avila-Levy CM. Effects of the calpain inhibitor MDL28170 on the clinically relevant forms of Trypanosoma cruzi in vitro. J Antimicrob Chemother2010 Jul;65(7):1395-8. Epub 2010 May 10.
Fampa P, Lisboa CV, Zahner V, Jansen AM, Ramirez MI. Wide proteolytic activity survey reinforces heterogeneity among Trypanosoma cruzi TCI and TCII wild populations. Vector Borne Zoonotic Dis. 2010 Nov;10(9):839-45. Epub 2010 Apr 26.
Fampa P, Santos AL, Ramirez MI. Trypanosoma cruzi: ubiquity expression of surface cruzipain molecules in TCI and TCII field isolates. Parasitol Res. 2010 Jul;107(2):443-7. Epub 2010 May 30.
doi |
Scielo |
doi |
doi |
Guedes PM, Oliveira FS, Gutierrez FR, da Silva GK, Rodrigues GJ, Bendhack LM, Franco DW, Do Valle Matta MA, Zamboni DS, da Silva RS, Silva JS. Nitric oxide donor trans-[RuCl([15]aneN4)NO]2+ as a possible therapeutic approach for Chagas´ disease. Br J Pharmacol. 2010 May;160(2):270-82. Epub 2010 Jan 27.
doi |
doi |
doi |
doi |
doi |
doi |
Olivieri BP, Vasconcellos R, Nóbrega A, Minoprio P, Kaveri SV, Araújo-Jorge TC. Intravenous immunoglobulin increases survival time in the acute phase of experimental Chagas disease. Parasite Immunol. 2010 Jun;32(6):464-9.
Scielo |
doi |
Salomão K, de Souza EM, Henriques-Pons A, Barbosa HS, de Castro SL.Brazilian green propolis: Effects in vitro and in vivo on Trypanosoma cruzi. Evid Based Complement Alternat Med. 2009 Mar 11.
Sarquis O, Carvalho-Costa FA, Oliveira LS, Duarte R, D Andrea PS, de Oliveira TG, Lima MM. J Ecology of Triatoma brasiliensis in northeastern Brazil: seasonal distribution, feeding resources, and Trypanosoma cruzi infection in a sylvatic population. Journal of Vector Ecology. 2010 Dec;35(2):385-94.
Silvério JC, de-Oliveira-Pinto LM, da Silva AA, de Oliveira GM, Lannes-Vieira J. Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection. Int J Exp Pathol. 2010 Feb;91(1):72-86. Epub 2009 Oct 28.
Souza AP, Jelicks LA, Tanowitz HB, Olivieri BP, Medeiros MM, Oliveira GM, Pires AR, Santos AM, Araújo-Jorge TC. The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice. Mem. Inst. Oswaldo Cruz. 2010 Sep;105(6):746-51.
Romanha AJ, Castro SL, Soeiro Mde N, Lannes-Vieira J, Ribeiro I, Talvani A, Bourdin B, Blum B, Olivieri B, Zani C, Spadafora C, Chiari E, Chatelain E, Chaves G, Calzada JE, Bustamante JM, Freitas-Junior LH, Romero LI, Bahia MT, Lotrowska M, Soares M, Andrade SG, Armstrong T, Degrave W, Andrade Zde A. In vitro and in vivo experimental models for drug screening and development for Chagas disease. Mem. Inst. Oswaldo Cruz. 2010 Mar;105(2):233-8.
Instituto Oswaldo Cruz /IOC /FIOCRUZ - Av. Brasil, 4365 - Tel: (21) 2598-4220
| INTRANET IOC| EXPEDIENTE
Manguinhos - Rio de Janeiro - RJ - Brasil CEP: 21040-360